Joshua Wang: PHD to Founder, Killing Cancer Using Trickery & Backlash vs. Personal Truth - E202

episode

BRAVE Southeast Asia Tech: Singapore, Indonesia, Vietnam, Philippines, Thailand & Malaysia Startups, Founders & Venture Capital VC (English) not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from BRAVE Southeast Asia Tech: Singapore, Indonesia, Vietnam, Philippines, Thailand & Malaysia Startups, Founders & Venture Capital VC (English)

What 500 Harvard Case Studies Actually Do To Your Brain - E729 55 min · 09 Sep 2026

The Truth About China's Competitive Advantage - E728 30 min · 06 Sep 2026

Itamar Novick: Where AI Replaces People, and Where It Does Not - E727 46 min · 02 Sep 2026

$70,000 Per Child: What Singapore's New Family Package Actually Changes - E726 43 min · 31 Aug 2026

The Next 3 Years Will Deliver 30 Years of Innovation | John Lin - E725 39 min · 26 Aug 2026

The Innovation Playbook of 3 Southeast Asian Founders - E724 27 min · 23 Aug 2026

All episodes from BRAVE Southeast Asia Tech: Singapore, Indonesia, Vietnam, Philippines, Thailand & Malaysia Startups, Founders & Venture Capital VC (English) →

Report any issue

Source

Recorded03 Oct 2022

Publisherfeed.pod.co ↗

Handlerec:7818361

Show notes

Joshua Wang, PhD is the Founder & CEO of VerImmune, an early biotechnology startup company developing a novel virus-inspired particle (ViP) technology platform that can be used as a delivery system to target multiple diseases. VerImmune’s first focus will be in Oncology whereby the ViP will enable the redirection of immune memory from past infections or childhood vaccinations to target cancer. His initial primary interest was in vaccine development and that led him to pursue an education at Imperial College London, UK and then later graduate training at Johns Hopkins. It was during this period where Joshua caught the “entrepreneurial bug.” Joshua also previously worked as a Venture Labs fellow at Flagship Pioneering, a world class venture creation firm focused on developing innovative companies with first-in-class medicines to serve critical unmet needs. Joshua considers himself an “accidental" bio-entrepreneur. He never intended to pursue biotech or start a business in drug development. Through serendipity and chance however, he found himself on this life-changing journey which has given him the privilege of developing potentially game changing treatment options to patients through the co-founding several startups, advising fellow aspiring founders, securing early-stage financing, partnerships with pharmaceuticals and operating early-stage biotech companies. Show notes at: https://www.jeremyau.com/blog/joshua-wang

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.